Clinical, serological, and hemodynamic factors associated with poor outcomes in systemic lupus erythematosus–associated pulmonary arterial hypertension: a multicenter retrospective study from Korea

Elevated mPAP, active lupus, and use of combination PAH therapy were independently associated with poor outcomes in SLE-PAH, highlighting the relevance of comprehensive hemodynamic assessment and careful management of lupus activity.